HOME >> BIOLOGY >> NEWS
Towards A Local Stimulation Of Natural Bypass Growth - Max Planck Scientists Developed New Treatment For Ischemic Heart Disease

Enhancing the bodies ability to create its own natural bypasses may soon become an alternative to baloon dilatation or bypass surgery. As reported in the February edition of Nature Biotechnology, scientists at the Max Planck Institute for Physiological and Clinical Research in Bad Nauheim/Germany have recently developed a non-invasive method to supply the diseased heart with vessel growth promoting factors making use of the property of microscopic beads to lodge in the peripheral vasculature. These beads are made to slowly release the growth factor without causing any damage.

Different growth factors have already been shown to promote the growth of new vessels. In particular Vascular Endothelial Growth Factor and Fibrobroblast Growth Factors have been subject to extensive research. However, whereas genes or proteins of these growth factors can simply be injected into peripheral tissues this is not possible in case of the heart. A systemic injection may also be deleterious since all of these growth factors have been shown to cause acute vascodilatation and may also promote tumor vessel growth. Attempts of vessel growth promoting therapies in the heart have therefore mainly been limited to cardiac surgery where the gene of a growth factor was given as adjunct to bypass surgery. The new method developed by Arras and collegues on the contrary requires only a routine catheterization procedure. Microscopic beads are injected into the vessel supplying the diseased territory and lodge in the peripheral capillary system whithout causing any damage. At this site they release the growth factor over a period of 7 days.

The major drawback of this method is that the growth factor will only be released within the diseased heart but not at the interface between healthy and diseased heart where large natural bypasses grow from smallest pre
'"/>

Contact: Wulf D. Ito
wito@kerckhoff.mpg.de
+49-6032-705402
Max-Planck-Gesellschaft
23-Feb-1998


Page: 1 2

Related biology news :

1. Towards an AIDS vaccine: unusual antibody that targets HIV described by scientists at TSRI
2. Local, regional governments could take lead in curbing global air pollution
3. Cedars-Sinai Scientists Localize New Ataxia/Epilepsy Gene
4. International Expert To Discuss Ramifications At Local Lecture...Tracking Contaminants In The Mighty Mississippi And Other Large Rivers Worldwide
5. Why Are The Fish Sick? Local Tip Suspected
6. Local Approaches To Combating Antibiotic Resistance Are Doomed To Failure
7. First Evidence That Localized Arthritis Gene Therapy Heals Distant Diseased Joints
8. Stimulation technique holds new promise for spinal cord injuries
9. Growth Factor Stimulation Leads To Increase In New Neurons In The Striatum And Cortex Of The Brain
10. Natural mineral locks up carbon dioxide
11. Naturalists of the Isthmus of Panama

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2020)... ... 2020 , ... Murrieta Genomics , the provider of genomics services and ... event on February 25th from 11:30 am to 1 pm at the University of ... are invited to attend this free event, but must register in advance . ...
(Date:2/13/2020)... ... February 13, 2020 , ... Worldwide Business ... Nobio CEO Yoram Ashery to discuss how their revolutionary technology can kill ... bacteria to keep people healthy with their revolutionary nanoparticle technology. Nobio is on ...
(Date:2/11/2020)... ... February 11, 2020 , ... The ... medical device accelerator in Port Covington, Baltimore. The newly formed company is developing ... addressed to manage increased demand for home dialysis treatments. The start-up company will ...
Breaking Biology News(10 mins):
(Date:1/22/2020)... ... January 21, 2020 , ... ... Taylor as Southern Midwest Region Industrial and Institutional (I&I) Account Manager. Darrell will ... , Darrell brings over 30 years of sales experience working across ...
(Date:1/10/2020)... ... January 09, 2020 , ... A new report ... for the vendor qualification process, a critical element of clinical trial set up ... of the vendor qualification process creates delays in initiation in 7% of clinical ...
(Date:1/8/2020)... (PRWEB) , ... January 08, 2020 , ... ... metal wire composites that can achieve specific properties for use in harsh environments ... Metal Wire combines up to three metals or alloys to achieve specific ...
(Date:1/7/2020)... HOBOKEN, N.J. (PRWEB) , ... January 07, 2020 , ... ... that prevent cancer progression and recurrence, today announced the appointments of Chand Khanna, DVM, ... Lampe, Co-founder and CEO of Vuja De said, “We are delighted to welcome Chand ...
Breaking Biology Technology:
Cached News: